CIT Program Tumor Identity Cards

{{refimprove|date=January 2022}}{{short description|Tumors research program}}

The "Cartes d'Identité des Tumeurs (CIT)" program,{{Cite web |date=2021-06-03 |title=Le programme « Cartes d'Identité des Tumeurs » {{!}} Ligue contre le cancer |url=https://www.ligue-cancer.net/articles/le-programme-cartes-didentite-des-tumeurs |access-date=2024-06-13 |website=www.ligue-cancer.net |language=fr}} launched and funded by the French charity "[https://www.ligue-cancer.net/ Ligue Nationale contre le Cancer]," aims to improve or develop better targeted therapeutic approaches by refining molecular knowledge of multiple types of tumors. The CIT program mainly relies on the large-scale and systematic profiling of large cohorts of tumors at various molecular levels including at least the genome, the epigenome, and the transcriptome.